Growth Metrics

Solid Biosciences (SLDB) Non-Current Deffered Revenue: 2017-2020

Historic Non-Current Deffered Revenue for Solid Biosciences (SLDB) over the last 2 years, with Dec 2020 value amounting to $10.4 million.

  • Solid Biosciences' Non-Current Deffered Revenue was N/A to $2.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $2.3 million, marking a year-over-year change of. This contributed to the annual value of $10.4 million for FY2020, which is N/A change from last year.
  • According to the latest figures from FY2020, Solid Biosciences' Non-Current Deffered Revenue is $10.4 million, which was up 233.52% from $3.1 million recorded in FY2017.
  • In the past 5 years, Solid Biosciences' Non-Current Deffered Revenue ranged from a high of $10.4 million in FY2020 and a low of $3.1 million during FY2017.
  • Its 1-year average for Non-Current Deffered Revenue is $10.4 million, with a median of $10.4 million in 2020.